Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Research Report 2021

Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Research Report 2021

Table of Contents
1 Proprotein Convertase Subtilisin/Kexin Type 9 Market Overview
1.1 Product Overview and Scope of Proprotein Convertase Subtilisin/Kexin Type 9
1.2 Proprotein Convertase Subtilisin/Kexin Type 9 Segment by Type
1.2.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 SX-PCK9
1.2.3 O-304
1.2.4 K-312
1.2.5 BLSM-201
1.2.6 DCRPCSK-9
1.2.7 Others
1.3 Proprotein Convertase Subtilisin/Kexin Type 9 Segment by Application
1.3.1 Proprotein Convertase Subtilisin/Kexin Type 9 Sales Comparison by Application: (2021-2027)
1.3.2 Cardiovascular Disease
1.3.3 Homozugous Familial Hyperchalesterolemia
1.3.4 Liver Disease
1.3.5 Metabolic Syndrome
1.3.6 Others
1.4 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Estimates and Forecasts
1.4.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue 2016-2027
1.4.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales 2016-2027
1.4.3 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Region: 2016 Versus 2021 Versus 2027
2 Proprotein Convertase Subtilisin/Kexin Type 9 Market Competition by Manufacturers
2.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Manufacturers (2016-2021)
2.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturing Sites, Area Served, Product Type
2.5 Proprotein Convertase Subtilisin/Kexin Type 9 Market Competitive Situation and Trends
2.5.1 Proprotein Convertase Subtilisin/Kexin Type 9 Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Proprotein Convertase Subtilisin/Kexin Type 9 Players Market Share by Revenue
2.5.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Proprotein Convertase Subtilisin/Kexin Type 9 Retrospective Market Scenario by Region
3.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Country
3.3.1 North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country
3.3.2 North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Country
3.4.1 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country
3.4.2 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Region
3.5.1 Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Region
3.5.2 Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Country
3.6.1 Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country
3.6.2 Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Country
3.7.1 Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country
3.7.2 Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Proprotein Convertase Subtilisin/Kexin Type 9 Historic Market Analysis by Type
4.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Type (2016-2021)
4.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Type (2016-2021)
4.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Price by Type (2016-2021)
5 Global Proprotein Convertase Subtilisin/Kexin Type 9 Historic Market Analysis by Application
5.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Application (2016-2021)
5.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Application (2016-2021)
5.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Price by Application (2016-2021)
6 Key Companies Profiled
6.1 AFFiRiS AG
6.1.1 AFFiRiS AG Corporation Information
6.1.2 AFFiRiS AG Description and Business Overview
6.1.3 AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AFFiRiS AG Product Portfolio
6.1.5 AFFiRiS AG Recent Developments/Updates
6.2 Betagenon AB
6.2.1 Betagenon AB Corporation Information
6.2.2 Betagenon AB Description and Business Overview
6.2.3 Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Betagenon AB Product Portfolio
6.2.5 Betagenon AB Recent Developments/Updates
6.3 Bioleaders Corp
6.3.1 Bioleaders Corp Corporation Information
6.3.2 Bioleaders Corp Description and Business Overview
6.3.3 Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bioleaders Corp Product Portfolio
6.3.5 Bioleaders Corp Recent Developments/Updates
6.4 BioLingus AG
6.4.1 BioLingus AG Corporation Information
6.4.2 BioLingus AG Description and Business Overview
6.4.3 BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Sales, Revenue and Gross Margin (2016-2021)
6.4.4 BioLingus AG Product Portfolio
6.4.5 BioLingus AG Recent Developments/Updates
6.5 Catabasis Pharmaceuticals Inc
6.5.1 Catabasis Pharmaceuticals Inc Corporation Information
6.5.2 Catabasis Pharmaceuticals Inc Description and Business Overview
6.5.3 Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Catabasis Pharmaceuticals Inc Product Portfolio
6.5.5 Catabasis Pharmaceuticals Inc Recent Developments/Updates
6.6 Dicerna Pharmaceuticals Inc
6.6.1 Dicerna Pharmaceuticals Inc Corporation Information
6.6.2 Dicerna Pharmaceuticals Inc Description and Business Overview
6.6.3 Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Dicerna Pharmaceuticals Inc Product Portfolio
6.6.5 Dicerna Pharmaceuticals Inc Recent Developments/Updates
6.7 Eli Lilly and Co
6.6.1 Eli Lilly and Co Corporation Information
6.6.2 Eli Lilly and Co Description and Business Overview
6.6.3 Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Eli Lilly and Co Product Portfolio
6.7.5 Eli Lilly and Co Recent Developments/Updates
6.8 Ensemble Therapeutics Corp
6.8.1 Ensemble Therapeutics Corp Corporation Information
6.8.2 Ensemble Therapeutics Corp Description and Business Overview
6.8.3 Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Ensemble Therapeutics Corp Product Portfolio
6.8.5 Ensemble Therapeutics Corp Recent Developments/Updates
6.9 Kowa Co Ltd
6.9.1 Kowa Co Ltd Corporation Information
6.9.2 Kowa Co Ltd Description and Business Overview
6.9.3 Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Kowa Co Ltd Product Portfolio
6.9.5 Kowa Co Ltd Recent Developments/Updates
6.10 Novartis AG
6.10.1 Novartis AG Corporation Information
6.10.2 Novartis AG Description and Business Overview
6.10.3 Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Novartis AG Product Portfolio
6.10.5 Novartis AG Recent Developments/Updates
6.11 Pfizer Inc
6.11.1 Pfizer Inc Corporation Information
6.11.2 Pfizer Inc Proprotein Convertase Subtilisin/Kexin Type 9 Description and Business Overview
6.11.3 Pfizer Inc Proprotein Convertase Subtilisin/Kexin Type 9 Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Pfizer Inc Product Portfolio
6.11.5 Pfizer Inc Recent Developments/Updates
6.12 Regeneron Pharmaceuticals Inc
6.12.1 Regeneron Pharmaceuticals Inc Corporation Information
6.12.2 Regeneron Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Description and Business Overview
6.12.3 Regeneron Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Regeneron Pharmaceuticals Inc Product Portfolio
6.12.5 Regeneron Pharmaceuticals Inc Recent Developments/Updates
6.13 Serometrix LLC
6.13.1 Serometrix LLC Corporation Information
6.13.2 Serometrix LLC Proprotein Convertase Subtilisin/Kexin Type 9 Description and Business Overview
6.13.3 Serometrix LLC Proprotein Convertase Subtilisin/Kexin Type 9 Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Serometrix LLC Product Portfolio
6.13.5 Serometrix LLC Recent Developments/Updates
6.14 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
6.14.1 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Corporation Information
6.14.2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Description and Business Overview
6.14.3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Product Portfolio
6.14.5 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Recent Developments/Updates
6.15 The Medicines Company
6.15.1 The Medicines Company Corporation Information
6.15.2 The Medicines Company Proprotein Convertase Subtilisin/Kexin Type 9 Description and Business Overview
6.15.3 The Medicines Company Proprotein Convertase Subtilisin/Kexin Type 9 Sales, Revenue and Gross Margin (2016-2021)
6.15.4 The Medicines Company Product Portfolio
6.15.5 The Medicines Company Recent Developments/Updates
7 Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturing Cost Analysis
7.1 Proprotein Convertase Subtilisin/Kexin Type 9 Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Proprotein Convertase Subtilisin/Kexin Type 9
7.4 Proprotein Convertase Subtilisin/Kexin Type 9 Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Proprotein Convertase Subtilisin/Kexin Type 9 Distributors List
8.3 Proprotein Convertase Subtilisin/Kexin Type 9 Customers
9 Proprotein Convertase Subtilisin/Kexin Type 9 Market Dynamics
9.1 Proprotein Convertase Subtilisin/Kexin Type 9 Industry Trends
9.2 Proprotein Convertase Subtilisin/Kexin Type 9 Growth Drivers
9.3 Proprotein Convertase Subtilisin/Kexin Type 9 Market Challenges
9.4 Proprotein Convertase Subtilisin/Kexin Type 9 Market Restraints
10 Global Market Forecast
10.1 Proprotein Convertase Subtilisin/Kexin Type 9 Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Proprotein Convertase Subtilisin/Kexin Type 9 by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Proprotein Convertase Subtilisin/Kexin Type 9 by Type (2022-2027)
10.2 Proprotein Convertase Subtilisin/Kexin Type 9 Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Proprotein Convertase Subtilisin/Kexin Type 9 by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Proprotein Convertase Subtilisin/Kexin Type 9 by Application (2022-2027)
10.3 Proprotein Convertase Subtilisin/Kexin Type 9 Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Proprotein Convertase Subtilisin/Kexin Type 9 by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Proprotein Convertase Subtilisin/Kexin Type 9 by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Proprotein Convertase Subtilisin/Kexin Type 9 Covered in This Study
Table 5. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Manufacturers (2016-2021)
Table 7. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Proprotein Convertase Subtilisin/Kexin Type 9 Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturing Sites and Area Served
Table 11. Manufacturers Proprotein Convertase Subtilisin/Kexin Type 9 Product Type
Table 12. Global Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Proprotein Convertase Subtilisin/Kexin Type 9 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Proprotein Convertase Subtilisin/Kexin Type 9 as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Region (2016-2021)
Table 17. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country (2016-2021)
Table 20. North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country (2016-2021)
Table 22. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country (2016-2021)
Table 24. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Region (2016-2021)
Table 30. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country (2016-2021)
Table 32. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country (2016-2021)
Table 38. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs) by Type (2016-2021)
Table 39. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Type (2016-2021)
Table 40. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue (Million US$) by Type (2016-2021)
Table 41. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Share by Type (2016-2021)
Table 42. Global Proprotein Convertase Subtilisin/Kexin Type 9 Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs) by Application (2016-2021)
Table 44. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Application (2016-2021)
Table 45. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue (Million US$) by Application (2016-2021)
Table 46. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Share by Application (2016-2021)
Table 47. Global Proprotein Convertase Subtilisin/Kexin Type 9 Price (USD/Pcs) by Application (2016-2021)
Table 48. AFFiRiS AG Corporation Information
Table 49. AFFiRiS AG Description and Business Overview
Table 50. AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 52. AFFiRiS AG Recent Developments/Updates
Table 53. Betagenon AB Corporation Information
Table 54. Betagenon AB Description and Business Overview
Table 55. Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 57. Betagenon AB Recent Developments/Updates
Table 58. Bioleaders Corp Corporation Information
Table 59. Bioleaders Corp Description and Business Overview
Table 60. Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 62. Bioleaders Corp Recent Developments/Updates
Table 63. BioLingus AG Corporation Information
Table 64. BioLingus AG Description and Business Overview
Table 65. BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 67. BioLingus AG Recent Developments/Updates
Table 68. Catabasis Pharmaceuticals Inc Corporation Information
Table 69. Catabasis Pharmaceuticals Inc Description and Business Overview
Table 70. Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 72. Catabasis Pharmaceuticals Inc Recent Developments/Updates
Table 73. Dicerna Pharmaceuticals Inc Corporation Information
Table 74. Dicerna Pharmaceuticals Inc Description and Business Overview
Table 75. Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 77. Dicerna Pharmaceuticals Inc Recent Developments/Updates
Table 78. Eli Lilly and Co Corporation Information
Table 79. Eli Lilly and Co Description and Business Overview
Table 80. Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 82. Eli Lilly and Co Recent Developments/Updates
Table 83. Ensemble Therapeutics Corp Corporation Information
Table 84. Ensemble Therapeutics Corp Description and Business Overview
Table 85. Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 87. Ensemble Therapeutics Corp Recent Developments/Updates
Table 88. Kowa Co Ltd Corporation Information
Table 89. Kowa Co Ltd Description and Business Overview
Table 90. Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 92. Kowa Co Ltd Recent Developments/Updates
Table 93. Novartis AG Corporation Information
Table 94. Novartis AG Description and Business Overview
Table 95. Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 97. Novartis AG Recent Developments/Updates
Table 98. Pfizer Inc Corporation Information
Table 99. Pfizer Inc Description and Business Overview
Table 100. Pfizer Inc Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Pfizer Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 102. Pfizer Inc Recent Developments/Updates
Table 103. Regeneron Pharmaceuticals Inc Corporation Information
Table 104. Regeneron Pharmaceuticals Inc Description and Business Overview
Table 105. Regeneron Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Regeneron Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 107. Regeneron Pharmaceuticals Inc Recent Developments/Updates
Table 108. Serometrix LLC Corporation Information
Table 109. Serometrix LLC Description and Business Overview
Table 110. Serometrix LLC Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Serometrix LLC Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 112. Serometrix LLC Recent Developments/Updates
Table 113. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Corporation Information
Table 114. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Description and Business Overview
Table 115. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 117. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Recent Developments/Updates
Table 118. The Medicines Company Corporation Information
Table 119. The Medicines Company Description and Business Overview
Table 120. The Medicines Company Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. The Medicines Company Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 122. The Medicines Company Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Proprotein Convertase Subtilisin/Kexin Type 9 Distributors List
Table 126. Proprotein Convertase Subtilisin/Kexin Type 9 Customers List
Table 127. Proprotein Convertase Subtilisin/Kexin Type 9 Market Trends
Table 128. Proprotein Convertase Subtilisin/Kexin Type 9 Growth Drivers
Table 129. Proprotein Convertase Subtilisin/Kexin Type 9 Market Restraints
Table 130. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Type (2022-2027) & (K Pcs)
Table 131. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share Forecast by Type (2022-2027)
Table 132. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 133. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share Forecast by Type (2022-2027)
Table 134. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Application (2022-2027) & (K Pcs)
Table 135. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share Forecast by Application (2022-2027)
Table 136. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 137. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share Forecast by Application (2022-2027)
Table 138. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Region (2022-2027) & (K Pcs)
Table 139. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share Forecast by Region (2022-2027)
Table 140. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 141. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share Forecast by Region (2022-2027)
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Proprotein Convertase Subtilisin/Kexin Type 9
Figure 2. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Type in 2020 & 2027
Figure 3. SX-PCK9 Product Picture
Figure 4. O-304 Product Picture
Figure 5. K-312 Product Picture
Figure 6. BLSM-201 Product Picture
Figure 7. DCRPCSK-9 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Application in 2020 & 2027
Figure 10. Cardiovascular Disease
Figure 11. Homozugous Familial Hyperchalesterolemia
Figure 12. Liver Disease
Figure 13. Metabolic Syndrome
Figure 14. Others
Figure 15. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2016-2027 (US$ Million)
Figure 17. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales 2016-2027 (K Pcs)
Figure 18. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 19. Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Manufacturers in 2020
Figure 20. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Share by Manufacturers in 2020
Figure 21. The Global 5 and 10 Largest Proprotein Convertase Subtilisin/Kexin Type 9 Players: Market Share by Revenue in 2020
Figure 22. Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 23. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Region (2016-2021)
Figure 24. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Region in 2020
Figure 25. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Region (2016-2021)
Figure 26. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Region in 2020
Figure 27. U.S. Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Canada Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Germany Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. France Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. U.K. Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Italy Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Russia Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Japan Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. South Korea Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. India Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Australia Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Taiwan Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Indonesia Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Thailand Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Malaysia Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Philippines Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Vietnam Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Mexico Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Brazil Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Argentina Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Turkey Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Saudi Arabia Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. U.A.E Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Sales Market Share of Proprotein Convertase Subtilisin/Kexin Type 9 by Type (2016-2021)
Figure 52. Sales Market Share of Proprotein Convertase Subtilisin/Kexin Type 9 by Application (2016-2021)
Figure 53. Sales Market Share of Proprotein Convertase Subtilisin/Kexin Type 9 by Application in 2020
Figure 54. Revenue Share of Proprotein Convertase Subtilisin/Kexin Type 9 by Application (2016-2021)
Figure 55. Revenue Share of Proprotein Convertase Subtilisin/Kexin Type 9 by Application in 2020
Figure 56. Manufacturing Cost Structure of Proprotein Convertase Subtilisin/Kexin Type 9
Figure 57. Manufacturing Process Analysis of Proprotein Convertase Subtilisin/Kexin Type 9
Figure 58. Proprotein Convertase Subtilisin/Kexin Type 9 Industrial Chain Analysis
Figure 59. Channels of D

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs